WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, M. A.
Right arrow Articles by Pasternak, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, M. A.
Right arrow Articles by Pasternak, G. W.

 Previous Article  |  Next Article 

The Journal of Neuroscience, October 1, 2001, 21(19):7788-7792

Potentiation of Opioid Analgesia in Dopamine2 Receptor Knock-Out Mice: Evidence for a Tonically Active Anti-Opioid System

Michael A. King1, Sheri Bradshaw2, Albert H. Chang1, John E. Pintar2, and Gavril W. Pasternak1

1 Laboratory of Molecular Neuropharmacology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, and 2 Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, New Jersey 08854

Dopamine systems are intimately involved with opioid actions. Pharmacological studies suggest an important modulatory effect of dopamine and its receptors on opioid analgesia. We have now examined these interactions in a knock-out model in which the dopamine2 (D2) receptor has been disrupted. Loss of D2 receptors enhances, in a dose-dependent manner, the analgesic actions of the µ analgesic morphine, the kappa 1 agonist U50,488H and the kappa 3 analgesic naloxone benzoylhydrazone. The responses to the delta  opioid analgesic [D-Pen2,D-Pen5]enkephalin were unaffected in the knock-out animals. Loss of D2 receptors also potentiated spinal orphanin FQ/nociceptin analgesia. Antisense studies using a probe targeting the D2 receptor revealed results similar to those observed in the knock-out model. The modulatory actions of D2 receptors were independent of sigma  receptor systems because the sigma  agonist (+)-pentazocine lowered opioid analgesia in all mice, including the D2 knock-out group. Thus, dopamine D2 receptors represent an additional, significant modulatory system that inhibits analgesic responses to µ and kappa  opioids.

Key words: analgesia; dopamine; dopamine receptor; D2 receptor; knock-out; antisense; anti-opioid; nociception; analgesic


Copyright © 2001 Society for Neuroscience  0270-6474/01/21197788-05$05.00/0


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
A. F. Viana, I. S. Maciel, E. M. Motta, P. C. Leal, L. Pianowski, M. M. Campos, and J. B. Calixto
Antinociceptive Activity of Trichilia catigua Hydroalcoholic Extract: New Evidence on its Dopaminergic Effects
Evid. Based Complement. Altern. Med., October 8, 2009; (2009) nep144v1.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Mei and G. W. Pasternak
Modulation of Brainstem Opiate Analgesia in the Rat by {sigma}1 Receptors: A Microinjection Study
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1278 - 1285.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. J. Scott, M. M. Heitzeg, R. A. Koeppe, C. S. Stohler, and J.-K. Zubieta
Variations in the human pain stress experience mediated by ventral and dorsal Basal Ganglia dopamine activity.
J. Neurosci., October 18, 2006; 26(42): 10789 - 10795.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K.-S. Kim, K.-W. Lee, K.-W. Lee, J.-Y. Im, J. Y. Yoo, S.-W. Kim, J.-K. Lee, E. J. Nestler, and P.-L. Han
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action.
PNAS, March 7, 2006; 103(10): 3908 - 3913.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Ellrich
Electric Low-Frequency Stimulation of the Tongue Induces Long-Term Depression of the Jaw-Opening Reflex in Anesthetized Mice
J Neurophysiol, December 1, 2004; 92(6): 3332 - 3337.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. H. Tran, R. Tamura, T. Uwano, T. Kobayashi, M. Katsuki, G. Matsumoto, and T. Ono
Altered accumbens neural response to prediction of reward associated with place in dopamine D2 receptor knockout mice
PNAS, June 25, 2002; 99(13): 8986 - 8991.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
M.-R. Zarrindast, Z. Dinkoub, H. Homayoun, A. Bakhtiarian, and S. Khavandgar
Dopamine receptor mechanism(s) and morphine tolerance in mice
J Psychopharmacol, May 1, 2002; 16(3): 261 - 266.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Mei and G. W. Pasternak
sigma 1 Receptor Modulation of Opioid Analgesia in the Mouse
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1070 - 1074.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-